Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06105892 · ClinicalTrials.gov registry record · NA
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
A NA study of Traumatic Brain Injury and Concussion, Mild, sponsored by New Jersey Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06105892: Recruiting NA study of Traumatic Brain Injury and Concussion, Mild, sponsored by New Jersey Institute of Technology.
NCT06105892 is a NA study of Traumatic Brain Injury and Concussion, Mild that is actively recruiting participants, run by New Jersey Institute of Technology. The registered enrollment target is 100 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06105892, a NA study of Traumatic Brain Injury and Concussion, Mild, is actively recruiting participants, sponsored by New Jersey Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test a portable virtual reality (VR) system with integrated eye tracking called Virtual Eye Rotation Vision Exercises (VERVE). The proposed VERVE platform will deliver vergence therapy in an automated manner. This research will involve 30 non-traumatic brain injury (TBI) binocularly normal (BNC) Veterans and 50 post-traumatic convergence insufficiency (PTCI) Veterans who will undergo Active and Sham therapy (equally divided groups) to determine the effectiveness of VERVE vergence therapy.
Primary Outcome
Normal range is \< 6 cm
Conditions Studied
Interventions
- DEVICE Virtual Eye Rotation Vision Exercise (VERVE)
- DEVICE Sham VR Therapy
Study Locations (1)
New Mexico
- New Mexico VA Health Care System - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-10-23 |
| Est. Completion | 2027-03-20 |
| Phase | NA |
What NCT06105892 shows while recruiting
NCT06105892 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (64% lower).
The record links to 3 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Virtual Eye Rotation Vision Exercise (VERVE) is the first listed.
NCT06105892 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT06105892 about?
NCT06105892 is a clinical study titled "Eye Recovery Automation for Post Injury Dysfunction (iRAPID)". This study will test a portable virtual reality (VR) system with integrated eye tracking called Virtual Eye Rotation Vision Exercises (VERVE). The proposed VERVE platform will deliver vergence therapy in an automated manner. This research will involve 30 non-traumatic brain injury (TBI) binocularly ...
What is the current status of trial NCT06105892?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-10-23. Estimated completion is 2027-03-20.
What conditions does trial NCT06105892 study?
This clinical trial studies the following conditions: Traumatic Brain Injury, Concussion, Mild, Convergence Insufficiency.
What interventions are being tested in trial NCT06105892?
The interventions under investigation include: Virtual Eye Rotation Vision Exercise (VERVE) (DEVICE), Sham VR Therapy (DEVICE).
Who is sponsoring clinical trial NCT06105892?
This trial is sponsored by New Jersey Institute of Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06105892 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06105892's enrollment target sits among peer trials
100 71st of 171 higher than 99 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Community-based Implementation of Online EmReg
RECRUITING · NA
-
Evaluation of the Abbott i-STAT TBI Biomarker Test
RECRUITING · NA
-
Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI